KR940701251A - 콜레스테롤-강하 토코페롤 동족체 - Google Patents
콜레스테롤-강하 토코페롤 동족체Info
- Publication number
- KR940701251A KR940701251A KR1019930703736A KR930703736A KR940701251A KR 940701251 A KR940701251 A KR 940701251A KR 1019930703736 A KR1019930703736 A KR 1019930703736A KR 930703736 A KR930703736 A KR 930703736A KR 940701251 A KR940701251 A KR 940701251A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- medicament
- dimethyl
- benzopyran
- dihydro
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
본 발명은 혈장 콜레스테롤 강하제로서 유용한 특정의 2H-1-벤조피란의 알킬아미노 알킬렌 유도체 및 치료제로서의 최종 용도에 관한 것이다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (17)
- (R) 및 (S) 에난티오머 및 라세미 혼합물, 및 약제학적으로 허용되는 염을 포함하는 하기 일반식(Ⅰ)의 화합물을 환자에게 유효량 투여함을 특징으로 하는, 혈장 콜레스테롤 강하용 약제의 제조시 이의 용도.상기식에서, R1및 R2는 각각 독립적으로 C1-6저급 알킬이고, R5는 H 또는 C1-6알킬이며, R6는 H 또는 -C(O)R(여기서, R은 H 또는 C1-9알킬이다)이고, R7은 H 또는 C1-6알킬이며, n은 1 내지 6의 정수이다.
- 제1항에 있어서, R5, R7및 R8이 메틸인 화합물의 약제로서 용도.
- 제1항에 있어서, R1및 R2가 메틸인 화합물의 약제로서 용도.
- 제1항에 있어서, R6이 H인 화합물의 약제로서 용도.
- 제1항에 있어서, R6이 -C(O)R(여기서, R은 제1항에서 정의한 바와 같다)인 화합물의 약제로서 용도.
- 제1항에 있어서, n이 2인 화합물의 약제로서 용도.
- 제6항에 있어서, R1, R2, R5, R7및 R8이 메틸인 화합물의 약제로서 용도.
- 제7항에 있어서, R6이 H인 화합물의 약제로서 용도.
- 제7항에 있어서, R6이 -C(O)R(여기서 R은 제1항에서 정의한 바와 같다)인 화합물의 약제로서 용도.
- 제1항에 있어서, 투여된 화합물이 3,4-디하이드로-2-(2-디메틸-아미노에틸)-2,5,7,8-테트라-메틸-2H-1-벤조피란-6-올 또는 약제학적으로 허용되는 이의 염인 화합물의 약제로서 용도.
- 제1항에 있어서, 투여된 화합물이 3,4-디하이드로-2-(2-디메틸-아미노에틸)-2,5,7,8-테트라-메틸-2H-벤조피란-6-일 아세테이트 또는 약제학적으로 허용되는 이의 염인 화합물의 약제로서 용도.
- 제1항에 있어서, 투여된 화합물이 3,4-디하이드로-2-(2-디메틸-아미노에틸)-2,7,8-트리메틸-2H-1-벤조피란-6-올 또는 약제학적으로 허용되는 이의 염인 화합물의 약제로서 용도.
- 제1항에 있어서, 투여된 화합물이 3,4-디하이드로-2-(2-디메틸-아미노에틸)-2,5,8-트리메틸-2H-1-벤조피란-6-올 또는 약제학적으로 허용되는 이의 염인 화합물의 약제로서 용도.
- 제1항에 있어서, 투여된 화합물이 3,4-디하이드로-2-(2-디메틸-아미노에틸)-2,5,7-트리메틸-2H-1-벤조피란-6-올 또는 약제학적으로 허용되는 이의 염인 화합물의 약제로서 용도.
- 제1항에 있어서, 투여된 화합물이 3,4-디하이드로-2-(2-디메틸-아미노에틸)-2,5,7,8-테트라메틸-6-(1,1-디메틸-에틸-카보닐옥시)-2H-1-벤조피란 또는 약제학적으로 허용되는 이의 염인 화합물의 약제로서 용도.
- 제1항에 있어서, 투여된 화합물이 3,4-디하이드로-2-(3-디메틸-아미노프로필)-2,5,7,8-테트라메틸-2H-1-벤조피란-6-올 또는 약제학적으로 허용되는 이의 염인 화합물의 약제로서 용도.
- 제1항에 따른 화합물을 이용하는 혈장 콜레스테롤 강하용의 약제로서 사용하기 위한 약제학적 제형.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/710,647 US5135945A (en) | 1991-06-05 | 1991-06-05 | Cholesterol-lowering tocopherol analogs |
US7/710647 | 1991-06-05 | ||
US07/710,647 | 1991-06-05 | ||
PCT/US1992/003738 WO1992021336A1 (en) | 1991-06-05 | 1992-05-06 | Cholesterol-lowering tocopherol analogs |
Publications (2)
Publication Number | Publication Date |
---|---|
KR940701251A true KR940701251A (ko) | 1994-05-28 |
KR100196973B1 KR100196973B1 (ko) | 1999-06-15 |
Family
ID=24854940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019930703736A KR100196973B1 (ko) | 1991-06-05 | 1992-05-06 | 콜레스테롤 강하용 약제학적 조성물 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5135945A (ko) |
EP (1) | EP0586518B1 (ko) |
JP (1) | JP3072912B2 (ko) |
KR (1) | KR100196973B1 (ko) |
AT (1) | ATE149830T1 (ko) |
AU (1) | AU665353B2 (ko) |
CA (1) | CA2102812C (ko) |
DE (1) | DE69218196T2 (ko) |
DK (1) | DK0586518T3 (ko) |
ES (1) | ES2101848T3 (ko) |
GR (1) | GR3023646T3 (ko) |
HU (1) | HUT65738A (ko) |
IE (1) | IE921811A1 (ko) |
NO (1) | NO304874B1 (ko) |
NZ (1) | NZ242982A (ko) |
WO (1) | WO1992021336A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2082004A1 (en) * | 1991-11-20 | 1993-05-21 | David Laffan | Substituted pentaalkylchromans |
WO1999037294A2 (en) | 1998-01-26 | 1999-07-29 | Mitokor | Mitochondria protecting agents for treating mitochondria associated diseases |
US6770672B1 (en) | 1998-09-23 | 2004-08-03 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
US6703384B2 (en) * | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
IL142082A (en) | 1998-09-23 | 2005-12-18 | Res Dev | Tocoflowers, tocotrinols, derivatives as a novel and other side-chain and their uses |
NZ520798A (en) * | 2000-02-11 | 2004-05-28 | Res Dev Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
US6436406B1 (en) * | 2000-06-15 | 2002-08-20 | A. Glenn Braswell | Compositions and methods for reducing or controlling blood cholesterol, lipoproteins, triglycerides and atherosclerosis |
US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
CA2479257A1 (en) * | 2002-03-21 | 2003-10-02 | Dana-Farber Cancer Institute, Inc. | Inhibition of cell death responses induced by oxidative stress |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321270A (en) * | 1981-01-29 | 1982-03-23 | E. R. Squibb & Sons, Inc. | Substituted chromans |
US4603142A (en) * | 1984-06-01 | 1986-07-29 | Wisconsin Alumni Research Foundation | Cholesterol lowering method of use |
US4681890A (en) * | 1984-10-30 | 1987-07-21 | Kuraray Co., Ltd. | 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same |
CA2002649C (en) * | 1988-11-14 | 2000-06-06 | Margaret Petty | Cardioprotective tocopherol analogs |
EP0369082A1 (en) * | 1988-11-14 | 1990-05-23 | Merrell Dow Pharmaceuticals Inc. | Cardioprotective tocopherol analogs |
KR910007523A (ko) * | 1989-10-04 | 1991-05-30 | 브리스톨-마이어즈 스퀴브 컴페니 | 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올 |
-
1991
- 1991-06-05 US US07/710,647 patent/US5135945A/en not_active Expired - Fee Related
-
1992
- 1992-05-06 EP EP92912113A patent/EP0586518B1/en not_active Expired - Lifetime
- 1992-05-06 DE DE69218196T patent/DE69218196T2/de not_active Expired - Fee Related
- 1992-05-06 HU HU9303446A patent/HUT65738A/hu unknown
- 1992-05-06 KR KR1019930703736A patent/KR100196973B1/ko not_active IP Right Cessation
- 1992-05-06 DK DK92912113.5T patent/DK0586518T3/da active
- 1992-05-06 CA CA002102812A patent/CA2102812C/en not_active Expired - Fee Related
- 1992-05-06 JP JP05500412A patent/JP3072912B2/ja not_active Expired - Fee Related
- 1992-05-06 ES ES92912113T patent/ES2101848T3/es not_active Expired - Lifetime
- 1992-05-06 AU AU19935/92A patent/AU665353B2/en not_active Ceased
- 1992-05-06 WO PCT/US1992/003738 patent/WO1992021336A1/en active IP Right Grant
- 1992-05-06 AT AT92912113T patent/ATE149830T1/de not_active IP Right Cessation
- 1992-06-02 NZ NZ242982A patent/NZ242982A/en unknown
- 1992-07-01 IE IE181192A patent/IE921811A1/en not_active IP Right Cessation
-
1993
- 1993-12-03 NO NO934397A patent/NO304874B1/no unknown
-
1997
- 1997-05-12 GR GR970401063T patent/GR3023646T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69218196T2 (de) | 1997-07-17 |
EP0586518A1 (en) | 1994-03-16 |
ATE149830T1 (de) | 1997-03-15 |
JP3072912B2 (ja) | 2000-08-07 |
NZ242982A (en) | 1997-03-24 |
JPH06508134A (ja) | 1994-09-14 |
WO1992021336A1 (en) | 1992-12-10 |
HUT65738A (en) | 1994-07-28 |
DE69218196D1 (de) | 1997-04-17 |
ES2101848T3 (es) | 1997-07-16 |
AU1993592A (en) | 1993-01-08 |
EP0586518B1 (en) | 1997-03-12 |
KR100196973B1 (ko) | 1999-06-15 |
NO934397L (no) | 1993-12-03 |
NO934397D0 (no) | 1993-12-03 |
DK0586518T3 (da) | 1997-04-01 |
IE921811A1 (en) | 1992-12-16 |
CA2102812C (en) | 2004-03-30 |
GR3023646T3 (en) | 1997-08-29 |
AU665353B2 (en) | 1996-01-04 |
NO304874B1 (no) | 1999-03-01 |
CA2102812A1 (en) | 1992-12-06 |
US5135945A (en) | 1992-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950017957A (ko) | 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체 | |
KR950031069A (ko) | 골손실의 억제 및 혈청 콜레스테롤의 강하 방법 | |
MX9300579A (es) | Derivados de pirazol, procedimientos para la preparacion de los mismos y a las composiciones farmaceuticas que comprenden a los mismos. | |
HUP0400710A2 (hu) | Tioéter helyettesítővel helyettesített imidazokinolinszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
DK0802911T3 (da) | Hydrofobe taxanderivater | |
ES2061204T3 (es) | Nuevos derivados de la amino-piperidina, de la amino-pirrolidina y de la amino-perhidroacepina, procedimientos de preparacion y composiciones farmaceuticas que los contienen. | |
ATE161836T1 (de) | 4-substituierte-2-deoxy-2,3-didehydro alpha-d- neuraminsäure antivirale derivate | |
KR890003382A (ko) | 항 비루스성 화합물 | |
KR940701251A (ko) | 콜레스테롤-강하 토코페롤 동족체 | |
DE69333723D1 (de) | Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen | |
BR0015364A (pt) | 5-benzil-2,4-diaminopirimidinas substituìdas | |
DE69312567D1 (de) | 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel | |
KR910004191A (ko) | 신질환치료제 | |
RU2218334C2 (ru) | Замещенные 1,2,3,4,5,6-гексагидро-2,6-метано-3-бензазоцин-10-олы и фармацевтическая композиция на их основе | |
KR940702491A (ko) | 옥사졸리돈 유도체 | |
ES2192241T3 (es) | Composiciones estables de proteccion a la luz que contienen derivados tensioactivos de glucosa y filtros uv solubles en agua. | |
KR950703941A (ko) | 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor) | |
DE69217613D1 (de) | Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen | |
HUP0001773A2 (hu) | Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények | |
KR890003371A (ko) | 신규 치료법 | |
KR970706825A (ko) | 헬리코박터의 감염에 기인하는 질환의 치료제(remedy for diseases caused by infection with helicobacter) | |
ATE285771T1 (de) | Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung | |
KR960028909A (ko) | 항-기생충 활성 | |
KR980002033A (ko) | 트리아졸 유도체 또는 그 염 | |
ATE102051T1 (de) | Arzneimittelzubereitungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20030214 Year of fee payment: 5 |
|
LAPS | Lapse due to unpaid annual fee |